Fehniger Named to Lymphoma Research Foundation Advisory Board
Joins group of lymphoma experts who guide organization’s research program
The Lymphoma Research Foundation has appointed Todd Fehniger, MD, PhD, a professor of medicine at Washington University School of Medicine in St. Louis, to its scientific advisory board.
Todd Fehniger, MD, PhD, a physician-scientist at Washington University School of Medicine in St. Louis who specializes in treating patients with lymphoma and developing innovative immune therapies to treat the disease, has been appointed a member of the scientific advisory board of the Lymphoma Research Foundation.
Fehniger treats patients at Siteman Cancer Center, based at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis. A professor of medicine, he also co-leads the Hematopoietic Development and Malignancy Program at Siteman.
The advisory board comprises 45 renowned lymphoma experts, who guide the planning of the foundation’s research program. They select innovative and promising research aimed at improving outcomes for patients with lymphoma, a broad term for cancer that begins in cells of the lymph system, which is part of the immune system.
Board members review grant proposals, make recommendations regarding research priorities and funding to the foundation’s board of directors, evaluate the progress of ongoing research projects, and guide the strategic direction of the foundation’s research programs and consortia.
